These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Quality control of PET imaging: from study to diagnosis]. Daisaki H Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(7):916-25. PubMed ID: 22821167 [No Abstract] [Full Text] [Related]
7. Brain: positron emission tomography tracers beyond [¹⁸F]fluorodeoxyglucose. Singhal T; Alavi A; Kim CK PET Clin; 2014 Jul; 9(3):267-76. PubMed ID: 25030390 [TBL] [Abstract][Full Text] [Related]
8. PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed. Kläsner BD; Krause BJ; Beer AJ; Drzezga A Expert Rev Anticancer Ther; 2010 May; 10(5):609-13. PubMed ID: 20469990 [No Abstract] [Full Text] [Related]
9. PET radiotracers for molecular imaging in the brain: past, present and future. Zimmer L; Luxen A Neuroimage; 2012 Jun; 61(2):363-70. PubMed ID: 22222719 [TBL] [Abstract][Full Text] [Related]
10. On the Origin of Hybrid Imaging. Lammertsma AA J Nucl Med; 2020 Dec; 61(Suppl 2):166S-167S. PubMed ID: 33293437 [No Abstract] [Full Text] [Related]
11. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose. Shiue CY; Welch MJ Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556 [TBL] [Abstract][Full Text] [Related]
12. Metastatic brain lesions may demonstrate photopenia on FDG-PET. Liu Y Clin Nucl Med; 2008 Apr; 33(4):255-7. PubMed ID: 18356662 [TBL] [Abstract][Full Text] [Related]
13. [Usefulness of 18F-FDG-PET in breast cancer imaging]. Tayama K; Toh U; Fujii T; Shirouzu K; Kaida Y Nihon Rinsho; 2007 Jun; 65 Suppl 6():373-8. PubMed ID: 17679209 [No Abstract] [Full Text] [Related]
14. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. Delbeke D J Nucl Med; 1999 Apr; 40(4):591-603. PubMed ID: 10210218 [TBL] [Abstract][Full Text] [Related]
15. [Practice guidelines for PDG-PET cancer screening]. Japanese Society of Nuclear Medicine Kaku Igaku; 2004 Nov; 41(4):1-21. PubMed ID: 15690769 [No Abstract] [Full Text] [Related]
17. The evolution of nuclear medicine and the musculoskeletal system. Palestro CJ; Love C; Schneider R Radiol Clin North Am; 2009 May; 47(3):505-32. PubMed ID: 19361673 [TBL] [Abstract][Full Text] [Related]
18. Quo Vadis: PET and Single-Photon Molecular Breast Imaging. Wahl RL J Nucl Med; 2016 Feb; 57 Suppl 1():3S-8S. PubMed ID: 26834100 [No Abstract] [Full Text] [Related]
19. Cerebral deafferentiation in operated gliomas as a predictor for malignancy? Otte A Eur J Nucl Med; 1999 Nov; 26(11):1523. PubMed ID: 10627178 [No Abstract] [Full Text] [Related]
20. Positron emission tomography of the brain. Macapinlac HA Neuroimaging Clin N Am; 2006 Nov; 16(4):591-603, viii. PubMed ID: 17148021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]